FDA authorizes protein-based COVID vaccine by Novavax
The FDA has authorized a COVID-19 vaccine developed by Novavax. Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, breaks down how this vaccine is different from the ones by Pfizer and Moderna, and whether it could persuade some hesitant Americans to finally get vaccinated.